Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

The objective of the JRC COVID-19 In Vitro Diagnostic Devices and Test Methods Database is to collect in a single place all publicly available information on performance of CE-marked in vitro diagnostic medical devices (IVDs) as well as laboratory-developed devices and related test methods for COVID-19. The database is manually curated and periodically updated.

Aim of the website 

Browse the data

  • COVID-19 in vitro diagnostic medical devices

    The database contains publicly available in vitro diagnostic medical devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark.
    Quick searches
    This section of the database is based on publicly available information from manufacturers.
    The conformity of the devices with applicable EU law has NOT been in any way assessed by the European Commission or Member State national authorities for the purposes of inclusion in the database. There is no central approval system for in vitro diagnostic medical devices in the EU and the database does NOT represent a list of authorised or approved devices in the European Union.
    For rapid antigen tests, as part of the EU Health Security Committee (HSC), the Member States have agreed on a common list of these tests considered appropriate for use in the context of COVID-19 diagnosis.
    For more information, please read “Aim of the website”.
  • SARS-CoV-2 NAAT target regions

    The database provides pre-computed values corresponding to the extent of matchings of the primers and probes from NAAT database methods against high-quality, full length genomic sequences, which are made available by GISAID to enable this analysis.
  • EUnetHTA publications repository

    EUnetHTA - European Network for Health Technology Assessment – developed a COVID-19-related repository of publications and outputs produced jointly or by individual HTA organisations on testing methods and devices for SARS-COV-2.
  • Explore the data

    This section allows surfing in and mining of data and analyses performed on SARS-CoV-2 sequences, like detectability of NAAT amplicons, and the phylodynamics of the pandemic in the European Union countries.


Information for manufacturers 

Related links